Reporting Erectile Function Outcomes After Radiation Therapy for Prostate Cancer: Challenges in Data Interpretation

Area of Science:

• Urology
• Radiation Oncology
• Sexual Medicine

Background:

• Choice of prostate cancer treatment is influenced by expected side effects like erectile dysfunction (ED).
• Significant discrepancies in reported ED rates exist in contemporary radiation therapy literature.

Purpose of the Study:

• To analyze reported ED rates following prostate cancer radiation therapy.
• To identify causes for discrepancies in ED rate reporting.
• To explore strengths and limitations of existing literature on radiation-induced ED.

Main Methods:

• Conducted a PubMed literature search for studies on ED rates after external-beam radiotherapy and brachytherapy.
• Reviewed 18 eligible studies published within the last 10 years.
• Focused on variables influencing erectile function outcomes, including patient and treatment characteristics.

Main Results:

• A wide variation in reported ED incidence was observed across studies.
• Discrepancies stemmed from differences in study populations, patient/treatment characteristics, androgen deprivation therapy, data acquisition, ED definitions, temporal factors, and erectile aid use.
• Incomplete reporting of essential data for sexual function outcome appraisal was noted.

Conclusions:

• The current literature on ED after prostate cancer radiation therapy has notable deficiencies.
• General recommendations for reporting erectile function outcomes are provided to enhance standardization and clinical interpretability.
• This review highlights the need for standardized reporting requirements for erectile function outcomes in prostate cancer radiation therapy.